Immunologic approaches to therapy for brain tumors.
Paul, David B. PhD 1; Kruse, Carol A. PhD 1
[Article] Current Neurology & Neuroscience Reports. 1(3):238-244, May 2001.

(Format: HTML, PDF)

: Malignant brain tumors are notoriously invasive. Although surgical debulking can relieve the patient of the main mass of tumor, adjuvant treatments are needed to target the glioma cells that infiltrate through normal parenchyma as single cells or pockets of tumor cells from which recurrent tumors arise. Successful adjuvant cellular therapy of brain tumors, or activation of endogenous immune cells, requires that either cell effectors make direct contact with tumor cells or come within close proximity to them and exert an indirect effect. This review examines current clinical trials aimed at direct lysis of glioma cells and trials making gliomas more visible to the endogenous immune system.

(C) 2001 Springer. Part of Springer Science Business Media